Should we keep using Ribavirin to Treat Hepatitis C Recurrence after Liver Transplantation? Results from the CO23 ANRS Cupilt Study - Archive ouverte HAL Access content directly
Journal Articles Journal of Hepatology Year : 2016

Should we keep using Ribavirin to Treat Hepatitis C Recurrence after Liver Transplantation? Results from the CO23 ANRS Cupilt Study

A. Coilly
  • Function : Author
V. de Ledinghen
  • Function : Author
V. Leroy
  • Function : Author
H. Montialoux
  • Function : Author
R. Anty
  • Function : Author
P. Perré
  • Function : Author
F. Durand
  • Function : Author
F. Habersetzer
  • Function : Author
M. Debette-Gratien
  • Function : Author
J. -C. Duclos-Vallee
  • Function : Author
G. -P. Pageaux
  • Function : Author

Abstract

EASL International Liver Congress, APR 13-17, 2016, Barcelona, SPAIN
Not file

Dates and versions

hal-01533345 , version 1 (06-06-2017)

Identifiers

Cite

P. Houssel-Debry, C. Duvoux, A. Coilly, C. Fougerou-Leurent, C. Jezequel, et al.. Should we keep using Ribavirin to Treat Hepatitis C Recurrence after Liver Transplantation? Results from the CO23 ANRS Cupilt Study. Journal of Hepatology, 2016, 64 (2), pp.S144--S145. ⟨10.1016/S0168-8278(16)01652-4⟩. ⟨hal-01533345⟩
85 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More